The Lancet Diabetes and Endocrinology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Type 1 diabetes—origins and epidemiology – Authors' reply
Publication date: May 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 5Author(s): Jill M Norris, Randi K Johnson, Lars C Stene (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - April 24, 2020 Category: Endocrinology Source Type: research

β-cell secretory dysfunction: a key cause of type 2 diabetes
Publication date: May 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 5Author(s): Rury R Holman, Anne Clark, Patrik Rorsman (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - April 24, 2020 Category: Endocrinology Source Type: research

β-cell secretory dysfunction: a key cause of type 2 diabetes – Authors' reply
Publication date: May 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 5Author(s): Gordon C Weir, Jason Gaglia, Susan Bonner-Weir (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - April 24, 2020 Category: Endocrinology Source Type: research

Giving NCDs the attention they deserve
Publication date: May 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 5Author(s): Jules Morgan (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - April 24, 2020 Category: Endocrinology Source Type: research

Lazy, Crazy, and Disgusting: Stigma and the Undoing of Global Health, Alexandra Brewis, Amber Wutich. Johns Hopkins University Press (2019), 288, $34·95, ISBN: 978-1-4214-3335-6
Publication date: May 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 5Author(s): Fiona Mitchell (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - April 24, 2020 Category: Endocrinology Source Type: research

Diabetes in Scotland: a rising tide
Publication date: May 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 5Author(s): Helen M Colhoun, John McKnight (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - April 24, 2020 Category: Endocrinology Source Type: research

Dose-response, efficacy, and safety of oral semaglutide monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): a 52-week, phase 2/3a, randomised, controlled trial
Publication date: May 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 5Author(s): Yuichiro Yamada, Hideki Katagiri, Yoshiyuki Hamamoto, Srikanth Deenadayalan, Andrea Navarria, Keiji Nishijima, Yutaka Seino, Y Fukushima, Y Hamamoto, A Hisatomi, Y Ide, S Inoue, T Kawada, H Kim, A Kiyosue, K Matoba, O Matsuoka, H Nishimura, M Noguchi, T Osonoi (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - April 24, 2020 Category: Endocrinology Source Type: research

Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial
Publication date: May 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 5Author(s): Daisuke Yabe, Jiro Nakamura, Hideaki Kaneto, Srikanth Deenadayalan, Andrea Navarria, Mette Gislum, Nobuya Inagaki, T Arisaka, T Asakura, N Azuma, S Fukuda, Y Fukushima, N Harada, S Inoue, H Ishida, H Ishii, S Ishikawa, H Jinnouchi, S Kaneko, K Kanno (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - April 24, 2020 Category: Endocrinology Source Type: research

Denosumab and cinacalcet for primary hyperparathyroidism (DENOCINA): a randomised, double-blind, placebo-controlled, phase 3 trial
Publication date: May 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 5Author(s): Julius Simoni Leere, Jesper Karmisholt, Maciej Robaczyk, Simon Lykkeboe, Aase Handberg, Emilie Steinkohl, Jens Brøndum Frøkjær, Peter Vestergaard (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - April 24, 2020 Category: Endocrinology Source Type: research

Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and meta-analysis of randomised cardiovascular outcome trials
Publication date: May 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 5Author(s): Olivia R Ghosh-Swaby, Shaun G Goodman, Lawrence A Leiter, Alice Cheng, Kim A Connelly, David Fitchett, Peter Jüni, Michael E Farkouh, Jacob A Udell (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - April 24, 2020 Category: Endocrinology Source Type: research

Risk factors and prevention strategies for diabetic ketoacidosis in people with established type 1 diabetes
Publication date: May 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 5Author(s): Dominic Ehrmann, Bernhard Kulzer, Timm Roos, Thomas Haak, Mohammed Al-Khatib, Norbert Hermanns (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - April 24, 2020 Category: Endocrinology Source Type: research

The importance of language in engagement between health-care professionals and people living with obesity: a joint consensus statement
Publication date: May 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 5Author(s): Charlotte Albury, W David Strain, Sarah Le Brocq, Jennifer Logue, Cathy Lloyd, Abd Tahrani, The Language Matters working group (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - April 24, 2020 Category: Endocrinology Source Type: research

Insulin access and affordability in the USA: anticipating the first interchangeable insulin product
Publication date: Available online 20 March 2020Source: The Lancet Diabetes & EndocrinologyAuthor(s): Jing Luo, Aaron S Kesselheim, Ameet Sarpatwari (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - March 21, 2020 Category: Endocrinology Source Type: research

BPA and risk assessment
Publication date: April 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 4Author(s): Kerri Palmer, Valerie Speirs (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - March 18, 2020 Category: Endocrinology Source Type: research

BPA and risk assessment
Publication date: April 2020Source: The Lancet Diabetes & Endocrinology, Volume 8, Issue 4Author(s): Antonia M Calafat, Holger M Koch, SS Andra, JP Antignac, A Castaño, K Choi, A Covaci, W Dekant, DR Doerge, H Frederiksen, T Göen, M Kolossa-Gehring, A Leblanc, JF Mueller, SF Nakayama, J Nassif, A St-Amand, W Völkel, MS Wolff (Source: The Lancet Diabetes and Endocrinology)
Source: The Lancet Diabetes and Endocrinology - March 18, 2020 Category: Endocrinology Source Type: research